Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All case investigation)

Trial Identifier:	D9603C00001
Sponsor:	AstraZeneca
Start Date:	June 2022
Primary Completion Date:	November 2025
Study Completion Date:	November 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Iwate, Japan
Japan	Nara, Japan
Japan	Tottori, Japan
Japan	Toyama, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.